Evaluation of PD-L1 expression in a large set of gastroenteropancreatic neuroendocrine tumours and correlation with clinicopathological data

BACKGROUND: Targeting programmed death protein 1 (PD-1) or its ligand PD-L1 is a promising therapeutic approach for many types of cancer in which PD-L1 is overexpressed. However, data on PD-L1 expression levels in gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are limited and contradicto...

Descripción completa

Detalles Bibliográficos
Autores principales: Rösner, Erik, Kaemmerer, Daniel, Sänger, Jörg, Lupp, Amelie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468575/
https://www.ncbi.nlm.nih.gov/pubmed/36067541
http://dx.doi.org/10.1016/j.tranon.2022.101526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468575/
https://www.ncbi.nlm.nih.gov/pubmed/36067541
http://dx.doi.org/10.1016/j.tranon.2022.101526

Ejemplares similares